Overview

Gender

female

Investor Type

Angel

Investor Stage

Seed

Carrie S. Cox is Executive Chairman and former Chief Executive Officer of Humacyte, Inc. She joined Humacyte in 2010 and previously served as Executive Vice President and President, Global Pharmaceuticals, at Schering-Plough Corporation from 2003 until its merger with Merck & Co., Inc. in November 2009. At Merck & Co., Inc., she was responsible for the company’s global prescription pharmaceutical business, which generated approximately $16 billion in annual sales. Carrie held a similar role as President, Global Prescription Business at Pharmacia Corporation, as well as Senior Vice President of Global Business Management at Pharmacia & Upjohn (the predecessor company to Pharmacia), and Vice President of Women’s Healthcare at Wyeth-Ayerst. Carrie spent her early career at Sandoz Pharmaceuticals in a variety of commercial roles of increasing responsibility. She currently serves on the Boards of Directors of Texas Instruments, Cardinal Health, and Celgene, and she has served as Lead Director for Texas Instruments.